Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Haelen Hyperbarics is a specialized healthcare provider focused on delivering medical-grade hyperbaric oxygen therapy (HBOT) in a clinical setting. Based in New York City, the company utilizes state-of-the-art hard-shell monoplace chambers to provide high-pressure oxygen treatments aimed at accelerating physiological healing and optimizing cellular function. Their services target a broad spectrum of conditions, ranging from FDA-approved indications like chronic wounds and radiation injury to health optimization and neurological recovery protocols. Led by experts in hyperbaric medicine, Haelen integrates HBOT with personalized health optimization strategies to improve patient outcomes in both restorative and preventative medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Haelen Hyperbarics.